Welcome
The BROD GROUP is a highly personalized, international Health Outcomes, Late Phase, and Market Access design and strategy consultancy. We conduct research that keeps the patient voice at the center of the drug development process.
The BROD GROUP expertise offers the Pharmaceutical and Biotech industry:
More than 35 years of real-world patient-centered research experience in Health Outcomes, Development of Clinical Outcome Assessments (COAs) to support labelling and promotional claims, and Late-Phase Research methodology, design, and implementation
A unique blend of experiences in academic, pharmaceutical, and contract research organizational settings, which allow us to have a 360° perspective on project design and logistics
We are Internationally recognized experts in the Design, Conduct, and Analysis of:
COA Development and Validation Studies for Health Outcome, Patient-Reported Outcome (PRO), Observer-Reported Outcome (ObsRO), and Caregiver Burden Measures
Qualitative Research Studies to investigate patients (children and adults), clinicians, caregivers, health care professionals, advocacy groups, and stakeholders
Studies to collect-real world data (RWD)
Late-Phase Clinical Trial Studies (peri- and post-launch)
The BROD GROUP experts write and disseminate research findings with:
A high acceptance rate of publications in peer-reviewed journals and presentations of findings at national and international conferences in the areas of Health Outcomes, Clinical Outcome Assessments, Research Methodology, Instrument Development, Quality of Life Research, Geriatrics and Gerontology
